About: Infecciones por el virus de Epstein-Barr y citomegalovirus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Infecciones por el virus de Epstein-Barr y citomegalovirus Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Infecciones por el virus de Epstein-Barr y citomegalovirus
Creator	Caro Gómez, N Leal, C López Tinoco, E Racero, I
Source	Elsevier; PMC
abstract	Resumen La infección por el virus de Epstein-Barr es la causa más frecuente de la mononucleosis infecciosa. Describimos su diagnóstico y los distintos patrones serológicos que se pueden presentar, así como sus principales complicaciones, relación con el desarrollo de neoplasias, síndromes linfoproliferativos y enfermedades autoinmunes. No existe un tratamiento efectivo. El citomegalovirus es la segunda causa de síndrome mononucleósido, la primera de infección congénita en nuestro medio y presenta gran morbimortalidad en los pacientes inmunodeprimidos, fundamentalmente trasplantados de órganos sólidos, médula ósea e infección por el virus de la inmunodeficiencia humana. Su tratamiento se basa en los antivíricos, sobre todo ganciclovir y valganciclovir. Describimos su manejo, efectos adversos, principales alternativas, nuevos fármacos y profilaxis. Abstract Infections by Epstein-Barr virus is the most common cause of infectious mononucleosis. We describe the diagnosis and different serological patterns, as well as its major complications related to the development of malignancies, lymphoproliferative disorders and autoimmune diseases. There is no effective treatment. Cytomegalovirus is the second cause of mononucleosis syndrome and the first of congenital infection in our environment. It has an high morbidity and mortality in immunocompromised patients, mainly solid organ transplants, bone marrow and coinfection by human immunodeficiency virus. Its treatment is based on antivirals, mainly ganciclovir and valganciclovir. We describe its management, adverse effects, new drugs and prophylaxis.
has issue date	2014-03-31(xsd:dateTime)
bibo:doi	10.1016/s0304-5412(14)70722-x
has license	els-covid
sha1sum (hex)	9288176e71e1e490eee56b7096a1f78f5c0677d2
schema:url	https://doi.org/10.1016/s0304-5412%2814%2970722-x
resource representing a document's title	Infecciones por el virus de Epstein-Barr y citomegalovirus
has PubMed Central identifier	PMC7143684
schema:publication	Medicine - Programa de Formación Médica Continuada Acreditado
resource representing a document's body	covid:9288176e71e1e490eee56b7096a1f78f5c0677d2#body_text
is schema:about of	named entity 'todo' named entity 'Epstein-Barr' named entity 'MONONUCLEOSIS' named entity 'BARR' named entity 'SUS' named entity 'A1S' named entity 'BASA' named entity 'GRAN' named entity 'EPSTEIN' named entity 'VIRUS' named entity 'QUE' named entity 'LOS' named entity 'VALGANCICLOVIR' named entity 'NEOPLASIAS' named entity 'EPSTEIN' named entity 'BARR' named entity 'VIRUS' named entity 'HUMANA' named entity 'POR' named entity 'TODO' named entity 'ENFERMEDADES' named entity 'GANCICLOVIR' named entity 'CAUSA' named entity 'CONG' named entity 'POR' named entity 'los' named entity 'neoplasias' named entity 'infección' named entity 'virus' named entity 'virus' named entity 'infección' named entity 'valganciclovir' named entity 'necrosis' named entity 'vitales' named entity 'infección' named entity 'vacuna' named entity 'hepatocarcinomas' named entity 'la cuarta' named entity 'infección' named entity 'IgG' named entity 'toxoplasmosis' named entity 'infección' named entity 'ganciclovir' named entity 'ganciclovir' named entity 'leucopenia' named entity 'Cidofovir' named entity 'ganciclovir' named entity 'el 1' named entity 'esta' named entity 'IgG' named entity 'más adelante' named entity 'BART' named entity 'SH2D1A' named entity '24 horas' named entity 'duodenitis' named entity 'resistencia' named entity 'Infección' named entity 'son la' named entity 'la segunda' named entity 'saliva' named entity 'LMP2' named entity 'CMX-001' named entity 'esta' named entity 'infección' named entity 'infección' named entity 'son la' named entity 'podemos' named entity 'usada' named entity 'ganciclovir' named entity 'infección' named entity 'LMP1' named entity 'son la' named entity 'maribavir' named entity 'monospot' named entity 'anemia' named entity 'vacuna' named entity 'TABLA' named entity 'anemia' named entity 'CD21' named entity 'aciclovir'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software